Extract of Alpinia officinarum suppresses enteropathogenic Escherichia coli (EPEC) lipopolysaccharide (LPS) induced inflammation in J774 A.1 macrophages

Journal of Health Science

Volumn 54, Issue 1, 2008, Pages 112-117

  Subramanian, Krishnan ^a   Selvakkumar, Chinnasamy ^a   Meenakshisundaram, Sankaranarayanan ^a   Balakrishnan, Arun ^b   Lakshmi, Baddireddi Subhadra ^a  

^a ANNA UNIVERSITY   (India)

^b Piramal Enterprises Limited   (India)

Author keywords

Alpinia officinarum; Enteropathogenic escherichia coli; Immunomodulator; Inflammation

Indexed keywords

ACETIC ACID ETHYL ESTER; ALPINIA OFFICINARUM EXTRACT; ENDOTOXIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PLANT EXTRACT; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIOLYSIS; CONTROLLED STUDY; DRUG ISOLATION; ENTERITIS; ENTEROPATHOGENIC ESCHERICHIA COLI; IMMUNE RESPONSE; INFLAMMATION; INTESTINE CELL; ISOLATION PROCEDURE; LAMINA PROPRIA; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN SECRETION;

ALPINIA OFFICINARUM; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MURINAE;

EID: 44449084769     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.54.112     Document Type: Article

References (23)

1. Clarke, S. C., Haigh, R. D., Freestone, P. P. E. and Williams, P. H. (2003) Virulence of Enteropathogenic E. coli, a global pathogen. Clin. Microbiol. Rev., 16, 365-378.
2. Savkovic, S. D., Koutsouris, A. and Hecht, G. (1997) Activation of NF-kappaB in intestinal epithelial cells by enteropathogenic Escherichia coli. Am. J. Physiol., 273, C1160-C1167.
3. Savkovic, S. D., Ramaswamy, A., Koutsouris, A. and Hecht, G. (2001) EPEC-activated ERK1/2 participate in inflammatory response but not tight junction barrier disruption. Am. J. Physiol. Gastrointest. Liver Physiol., 281, G890-G898.
4. Savkovic, S. D., Koutsouris, A. and Hecht, G. (2003) PKCzeta participates in activation of inflammatory response induced by enteropathogenic E.coli. Am. J. Physiol. Cell Physiol., 285, C512-C521.
5. Savkovic, S. D., Koutsouris, A. and Hecht, G. (1996) Attachment of a noninvasive enteric pathogen, enteropathogenic Escherichia coli, to cultured human intestinal epithelial monolayers induces transmigration of neutrophils. Infect. Immun., 64, 4480-4487.
6. Creasey, E. A., Delahay, R. M., Bishop, A. A., Shaw, R. K., Kenny, B., Knutton, S. and Frankel, G. (2003) CesT is a bivalent enteropathogenic Escherichia coli chaperone required for translocation of both Tir and Map. Mol. Microbiol., 47, 209-221.
7. Ruchaud-Sparagano, M.-H., Maresca, M. and Kenny, B. (2007) Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function. Cell. Microbiol., 9(8), 1909-21.
8. Goosney, D. L., Celli, J., Kenny, B. and Finlay, B. B. (1999) Enteropathogenic Escherichia coli Inhibits Phagocytosis. Infect. Immun., 67, 490-495.
9. Zhou, X., Giron, J. A., Torres, A. G., Crawford, J. A., Negrete, E., Vogel, S. N. and Kaper, J. B. (2003) Flagellin of enteropathogenic Escherichia coli stimulates interleukin-8 production in T84 cells. Infect. Immun., 71, 2120-2129.
10. Malladi, V., Puthenedam, M., Williams, P. H. and Balakrishnan A. (2004) Enteropathogenic Escherichia coli outer membrane preparations induce iNOS by activation of NfkappaB and MAP kinases. Inflammation, 28, 345-353.
11. Gayathri, B., Manjula, N., Vinaykumar, K. S., Lakshmi, B. S. and Balakrishnan, A. (2007) Pure compound from Boswellia serrata extract exhibits anti-inflammatory property in human PBMCs and mouse macrophages through inhibition of TNFα, IL-1β, NO and MAP kinases. Int. Immunopharmacol., 7, 473-482.
12. Hirschfeld, M., Ma, Y., Weis, J. H., Vogel, S. N. and Weis, J. J. (2000) Repurification of Lipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like Receptor-2. J. Immunol., 165, 618-622.
13. Hitchcock, P. J. and Brown, T. M. (1983) Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J. Bacteriol., 154, 269-277.
14. Wu, T. L. and Larsen, K. (2000) Family Zingiberaceae. In Flora of China, (Wu, Z. G. and Raven, P. H. Eds.), Science Press, Beijing, China, and Missouri Botanical Garden Press, St. Louis, Missouri, U.S.A., vol.24, pp.322-377.
15. Berkes, J., Viswanathan, V. K., Savkovic, S. D. and Hecht, G. (2003) Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut, 52, 439-451.
16. Buijs, J., Dofferhoff, A. S. M., Mouton, J. W. and van der Meer, J. W. M. (2006) Pathophysiology of in-vitro induced filaments, spheroplasts and rodshaped bacteria in neutropenic mice. Clin. Microbiol. Infect., 12(11), 1105-1111.
17. Heine, H. and Lien, H. (2003) Toll-like receptors and their function in innate and adaptive immunity. Arch. Allergy Immunol., 130, 180-192.
18. Dinarello, C. A. (2001) Proinflammatory cytokines, Chest, 118, 503-508.
19. Selvakkumar, C., Gayathri, B., Vinay Kumar, K. S., Lakshmi, B. S. and Balakrishnan, A. (2007) Potential Anti-inflammatory Properties of Crude Alcoholic Extract of Ocimum Basilicum L. in Human Peripheral Blood Mononuclear Cells. J. Health Sci., 53, 500-505.
20. Yadav, P. N., Liu, Z. and Rafi, M. M. (2003) A Diarylheptanoid from Lesser Galangal (Alpinia officinarum) Inhibits Proinflammatory Mediators via Inhibition of Mitogen-Activated Protein Kinase, p44/42, and Transcription Factor Nuclear Factor-KB J Pharmacol. Exp. Ther., 305(3), 925-31.
21. Thomas, E., Shanmugam, J. and Rafi, M. M. (1996) Antibacterial activity of plants belonging to Zingiberaceae family. Biomedicine, 16, 15-20.
22. Ameye, L. G. and Chee, W. S. S. (2006) Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic reviewof the scientific evidence. Arthritis Research & Therapy., 8:R127.
23. Wang, J., Zhou, H., Zheng, J., Cheng, J., Liu, W., Ding, G., Wang, L., Luo, P., Lu, Y., Cao, H., Yu, S., Li, B. and Zhang, L. (2006) The Antimalarial Artemisinin Synergizes with Antibiotics To Protect against Lethal Live Escherichia coli Challenge by Decreasing Proinflammatory Cytokine Release. Antimicrobial Agents Chemother., 50, 2420-2427.